跳至主要内容
临床试验/NCT07662200
NCT07662200尚未招募1 期

A Pilot Feasibility Study of a Steroid-Sparing Anti-Nausea and Vomiting Regimen With Netupitant/Palonosetron for Patients With Germ Cell Tumours Receiving Multi-Day Cisplatin-Based Chemotherapy at The Ottawa Hospital

Ottawa Hospital Research Institute1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2026年8月1日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
入组人数
10
试验地点
1

研究概览

简要总结

This is a single-site, open-label, randomized pilot feasibility study conducted at The Ottawa Hospital Cancer Centre. A total of 10 participants will be randomized 1:1 to either the experimental or control arm.

The purpose of this study is to evaluate recruitment capability, intervention adherence, data completeness, and safety prior to consideration of a potential future multi-centre randomized trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of germ cell cancer
  • Indication for outpatient treatment using a standard 5-day cisplatin-based chemotherapy regimen

排除标准

  • 未提供

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验